Company Profiles

driven by the PitchBook Platform

Seventh Sense Biosystems

Seventh Sense Biosystems
2007 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series C LATEST DEAL TYPE
$12.5M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of a blood collection device designed to make blood testing more convenient and virtually painless. The company's proprietary blood collection platform TAP (Touch Activated Phlebotomy) is the world's first push-button blood collection device a blood collection platform that enables blood to be drawn through a virtually painless, one-step process.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
200 Boston Avenue
Suite 3700
Medford, MA 02155
United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Seventh Sense Biosystems’s full profile, request a free trial.

Seventh Sense Biosystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series C) 18-Oct-2017 $12.5M 000.00 00000 Completed Generating Revenue
9. Later Stage VC 22-Dec-2015 00.000 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 06-Aug-2015 0000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series A) 18-Jun-2014 00.00 000.00 000.00 Completed Generating Revenue
6. Early Stage VC (Series A) 19-Jun-2012 000.00 0000 000.00 Completed Startup
5. Grant 16-Dec-2011 00.000 000.00 Completed Startup
4. Early Stage VC 10-May-2011 00.000 000.00 Completed Startup
3. Grant 21-Oct-2009 00.000 Completed Startup
2. Early Stage VC (Series A) 17-Dec-2008 $4.18M $4.18M 0000 Completed Startup
1. Early Stage VC 01-Jan-2007 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Seventh Sense Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 102,900,000 $0.001000 8% $0.2 $0.2 1x $0.2 50.76%
To view this company’s complete Cap Table, request access »

Seventh Sense Biosystems Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ionis Pharmaceuticals Corporation 000 0000 000000 0
Laboratory Corporation of America Holdings Corporation Minority 000 0000 000000 0
Next47 Corporate Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Lighthouse Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Seventh Sense Biosystems Executive Team (9)

Name Title Board
Seat
Contact
Info
Timothy Richards Chief Operating Officer
Stuart Blitz Chief Business Officer
Joerg Lahann Ph.D Co-Founder & Scientific Advisor
Samir Mitragotri Ph.D Co-Founder & Scientific Advisor
Jerry Brightbill Vice President, Engineering and Manufacturing Operations

2 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Seventh Sense Biosystems Board Members (13)

Name Representing Role Since Contact
Info
Alan Crane Polaris Partners Board Member 000 0000
Anupendra Sharma Next47 Board Member 000 0000
Donald Hardison Self Board Member 000 0000
Harry Wilcox Flagship Pioneering Board Member 000 0000
Howard Weisman Self Chief Executive Officer, President & Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com